These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2238127)

  • 1. Minimal bactericidal and inhibitory concentrations of ofloxacin on Mycobacterium fortuitum at pH 7 and 5: therapeutic implications.
    Yew WW; Kwan SY; Ma WK; Lui KS
    Tubercle; 1990 Sep; 71(3):205-8. PubMed ID: 2238127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postantibiotic effects of amikacin and ofloxacin on Mycobacterium fortuitum.
    Tsui SY; Yew WW; Li MS; Chan CY; Cheng AF
    Antimicrob Agents Chemother; 1993 May; 37(5):1001-3. PubMed ID: 8517688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single daily-dose ofloxacin monotherapy for Mycobacterium fortuitum sternotomy infection.
    Yew WW; Kwan SY; Ma WK; Khin MA; Mok CK
    Chest; 1989 Nov; 96(5):1150-2. PubMed ID: 2805845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative antimycobacterial activities of ofloxacin, ciprofloxacin and grepafloxacin.
    Vacher S; Pellegrin JL; Leblanc F; Fourche J; Maugein J
    J Antimicrob Chemother; 1999 Nov; 44(5):647-52. PubMed ID: 10552981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro and in vivo activity of fleroxacin and ofloxacin against various mycobacteria.
    Tomioka H; Sato K; Saito H
    Tubercle; 1991 Sep; 72(3):176-80. PubMed ID: 1771676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro activities of quinolones against mycobacteria.
    Garcia-Rodriguez JA; Gomez Garcia AC
    J Antimicrob Chemother; 1993 Dec; 32(6):797-808. PubMed ID: 8144420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of the in vitro susceptibility of 220 Mycobacterium fortuitum isolates to ten antimicrobial agents.
    Hernández AM; Arias A; Felipe A; Alvarez R; Sierra A
    J Chemother; 1995 Dec; 7(6):503-8. PubMed ID: 8667033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary study of the in vitro activity of irloxacin against mycobacteria.
    Casal M; Gutierrez J; Ruiz P; Moreno G
    Chemotherapy; 1995; 41(3):204-7. PubMed ID: 7656667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of roxithromycin against 16 species of atypical mycobacteria and effect of pH on its radiometric MICs.
    Rastogi N; Goh KS; Bryskier A
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1560-2. PubMed ID: 8363393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of different test conditions on the susceptibility of Mycobacterium fortuitum and Mycobacterium chelonae to amikacin.
    Hansen KT; Clark RB; Sanders WE
    J Antimicrob Chemother; 1994 Mar; 33(3):483-94. PubMed ID: 8040113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial activity of ofloxacin and other agents against mycobacterial isolates from postoperative sternotomy wounds.
    Yew WW; Kwan SY; Ma WK; Lui KS; Aung MK
    Clin Ther; 1989; 11(6):775-85. PubMed ID: 2611821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Port-site infections by nontuberculous mycobacterium: A retrospective clinico-microbiological study.
    Ghosh R; Das S; De A; Kela H; Saha ML; Maiti PK
    Int J Mycobacteriol; 2017; 6(1):34-37. PubMed ID: 28317802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis, M. avium, M. africanum, M. kansasii and BCG strains].
    Thomas L; Naumann P; Crea A
    Immun Infekt; 1986 Nov; 14(6):203-7. PubMed ID: 3100424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to sulfadiazine, sulfisoxazole and sulfathiazole.
    Casal M; Rodriguez F
    Eur J Clin Microbiol; 1984 Aug; 3(4):320-1. PubMed ID: 6489322
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibiotic resistance in
    Jayasingam SD; Zin T; Ngeow YF
    Int J Mycobacteriol; 2017; 6(4):387-390. PubMed ID: 29171453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibility of Mycobacterium marinum to dihydromycoplanecin A and ten other antimicrobial agents.
    Arai H; Nakajima H; Kaminaga Y
    J Dermatol; 1990 Jun; 17(6):370-4. PubMed ID: 2384640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfonamide activity against Mycobacterium fortuitum and Mycobacterium chelonei.
    Wallace RJ; Jones DB; Wiss K
    Rev Infect Dis; 1981; 3(5):898-904. PubMed ID: 7339821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility testing of rapidly growing mycobacteria isolated in Japan.
    Hatakeyama S; Ohama Y; Okazaki M; Nukui Y; Moriya K
    BMC Infect Dis; 2017 Mar; 17(1):197. PubMed ID: 28270102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of ofloxacin and amikacin in the treatment of sternotomy wound infection.
    Yew WW; Kwan SY; Ma WK; Aung-khin M; Mok CK
    Chest; 1989 May; 95(5):1051-5. PubMed ID: 2707062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro and in-vivo activity of DR-3355, an optically active isomer of ofloxacin.
    Tanaka M; Otsuki M; Une T; Nishino T
    J Antimicrob Chemother; 1990 Nov; 26(5):659-66. PubMed ID: 2079448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.